| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OLLI | Common Stock, par value $0.001 per share | Options Exercise | $0 | +758 | +18.09% | $0.00 | 4.95K | Apr 1, 2025 | Direct | F1, F2 |
| transaction | OLLI | Common Stock, par value $0.001 per share | Tax liability | -$37.6K | -328 | -6.63% | $114.55 | 4.62K | Apr 1, 2025 | Direct | F3, F4 |
| transaction | OLLI | Common Stock, par value $0.001 per share | Options Exercise | $99.5K | +1.72K | +37.13% | $57.98 | 6.34K | Apr 3, 2025 | Direct | F5 |
| transaction | OLLI | Common Stock, par value $0.001 per share | Sale | -$195K | -1.72K | -27.08% | $113.53 | 4.62K | Apr 3, 2025 | Direct | F5, F6 |
| transaction | OLLI | Common Stock, par value $0.001 per share | Options Exercise | $101K | +2.33K | +50.34% | $43.21 | 6.95K | Apr 3, 2025 | Direct | F5 |
| transaction | OLLI | Common Stock, par value $0.001 per share | Sale | -$264K | -2.33K | -33.48% | $113.53 | 4.62K | Apr 3, 2025 | Direct | F5, F6 |
| transaction | OLLI | Common Stock, par value $0.001 per share | Options Exercise | $107K | +1.44K | +31.23% | $74.23 | 6.06K | Apr 3, 2025 | Direct | F5 |
| transaction | OLLI | Common Stock, par value $0.001 per share | Sale | -$164K | -1.44K | -23.8% | $113.53 | 4.62K | Apr 3, 2025 | Direct | F5, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OLLI | Restricted Stock Units | Options Exercise | $0 | -758 | -25.01% | $0.00 | 2.27K | Apr 1, 2025 | Common Stock | 758 | Direct | F1, F7, F8 | |
| transaction | OLLI | Employee Stock Option (right to buy) | Award | $0 | +4.1K | $0.00 | 4.1K | Apr 1, 2025 | Common Stock | 4.1K | $114.55 | Direct | F9 | |
| transaction | OLLI | Restricted Stock Units | Award | $0 | +1.96K | $0.00 | 1.96K | Apr 1, 2025 | Common Stock | 1.96K | Direct | F7, F10 | ||
| transaction | OLLI | Employee Stock Option (right to buy) | Options Exercise | $0 | -1.72K | -20% | $0.00 | 6.87K | Apr 3, 2025 | Common Stock | 1.72K | $57.98 | Direct | F5, F11 |
| transaction | OLLI | Employee Stock Option (right to buy) | Options Exercise | $0 | -2.33K | -50% | $0.00 | 2.33K | Apr 3, 2025 | Common Stock | 2.33K | $43.21 | Direct | F5, F12 |
| transaction | OLLI | Employee Stock Option (right to buy) | Options Exercise | $0 | -1.44K | -24.82% | $0.00 | 4.37K | Apr 3, 2023 | Common Stock | 1.44K | $74.23 | Direct | F5, F13 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Represents the conversion upon vesting of restricted stock awards into common stock ("Common Stock"). |
| F2 | Restricted Stock Units ("RSUs") convert into Common Stock on a one-for-one basis. |
| F3 | Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the reporting person and cancelled by the issuer in exchange for the issuer's agreement to pay federal and state tax withholding obligations of the reporting person resulting from the vesting of restricted stock units. |
| F4 | The price reported in column 4 is equivalent to the fair market value based on the closing market price as of April 1, 2025. |
| F5 | Transactions made pursuant to an agreement adopted on December 19, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| F6 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.53-115.00, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | Each of the RSUs represents a contingent right to receive one share of Common Stock at vesting. |
| F8 | The RSUs vest and become exercisable in 25% installments on each anniversary date of the grant, April 1, 2024, subject to continued service through each applicable vesting date. The reporting person was granted 3,031 RSUs, of which 758 vested on April 1, 2025; 758 vest on April 1, 2026; 757 vest on April 1, 2027; and 758 vest on April 1, 2028. |
| F9 | Options vest and become exercisable in 25% installments on each anniversary date of the grant, April 1, 2025, subject to continued service through each applicable vesting date. The reporting person was granted 4,103 options, of which 1,026 vest on April 1, 2026; 1,026 vest on April 1, 2027; 1,025 vest on April 1, 2028; and 1,026 vest on April 1, 2029. |
| F10 | RSUs vest and become exercisable in 25% installments on each anniversary date of the grant, April 1, 2025, subject to continued service through each applicable vesting date. The reporting person was granted 1,964 RSUs, of which 491 vest on April 1, 2026; 491 vest on April 1, 2027; 491 vest on April 1, 2028; and 491 vest on April 1, 2029. |
| F11 | Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 23, 2023, subject to continued service through each applicable vesting date. The reporting person was granted 6,866 options, of which 1,717 vested on March 23, 2024; 1,716 vested on March 23, 2025; 1,717 vest on March 23, 2026; and 1,716 vest on March 23, 2027. |
| F12 | Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 25, 2022, subject to continued service through each applicable vesting date. The reporting person was granted 9,305 options, of which 2,326 vested on March 25, 2023; 2,327 vested on March 25, 2024; 2,326 vested on March 25, 2025; and 2,326 vest on March 25, 2026. |
| F13 | Options vest and become exercisable in 25% installments on each anniversary date of the grant, April 1, 2024, subject to continued service through each applicable vesting date. The reporting person was granted 5,815 options, of which 1,454 vested on April 1, 2025; 1,454 vest on April 1, 2026; 1,453 vest on April 1, 2027; and 1,454 vest on April 1, 2028. |